Legapas film-coated tablets, 20 pcs

Upute za korištenje Legapas film-coated tablets, 20 pcs

Important notes (compulsory information):

Legapas film-coated tablets. Active substance: Rhamnus Purshianus D.C. Applications: Constipation, for short-term use.

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


Insurance information

Legapas® tablets

Active substance:
Cascarary dry extract

Composition:
1 film tablet contains: Dropping active ingredient: Dry extract (4.2-5: 6: 1) from Cascarary 57-108 mg, accordingly 20 mg hydroxyanthrate derivatives, calculated as Cascaroside A
(Extract means: ethanol 52% m / m).
Other ingredients:
Lactose monohydrate, potato starch, talc, high-disperses silica, magnesium stearate, basic polymethacrylate, macrogol 6000, titanium dioxide, iron oxide / hydroxides.

Dosage form and content:
Original packs with 20 and 40 film-coated tablets.

Cloth or indicator group:
Herbal stimulating laxative.

Company and address of the pharmaceutical entrepreneur and manufacturer:
PASCOE pharmazeutische Präparate GmbH, Schiffenberger Weg 55, D-35394 Giessen or Groß Receiver Postal Code D-35383 Giessen, Tel. 0641 / 7960-0, Fax 0641 / 7960-109, E-mail: [email protected]

Application areas:
For short-term use in constipation (constipation).
In case of constipation, which lasts longer than 1 week, a doctor is to visit.

Contraindications:
When may you not use Legapas® tablets?
Legapas® tablets must not be used in known hypersensitivity (allergy) against Cascararinde or any of the other ingredients of the drug, in intestinal closure, blind dartitis, chronic inflammatory bowel disorders such. B. Crohn's disease, ulcerative colitis; For abdominal pain unknown
Cause as well as in heavy fluid deficiency with water and salt losses.

What do you need to consider in pregnancy and lactation?
Because of insufficient toxicological examinations are Legapas® Do not apply tablets in pregnancy and lactation.

What should be considered in children?
Children under 12 years may not take Legapas® tablets.

When may you use Legapas® tablets only after consulting the doctor?
With simultaneous ingestion of certain, heart-muscular drugs (heart glycosides), means against cardiac arrhythmias (antiarrhythmics), drugs that increase urinary excretion (diuretics), cortisone and cortisone-like substances (adrenal tongue steroids) and liquorice root.

Precautions for the application and warnings:
An intake beyond the short-lasting application The integer activity of stimulating (stimulating) laxative can lead to a reinforcement of the intestinal inlet. The preparation should be used only if the clogging is not to be remedied by the nutritional change or by swelling supplements.
Note:
In incontinent adults (with uncontrolled stool departure) If there is a longer skin contact with the feces by changing the template when taking Legapas® tablets are avoided.

Interactions with other means:
In continuous use or abuse, potassium deficiency is enhanced by the effect of certain, the heart muscle strengthening medicines (heart glycosides) as well as an influence of the effect of means against cardiac arrhythmias (antiarrhythmics). The potassium losses can be used simultaneous use of certain medicines that increase urinary excretion (Diuretics), Cortisone and Cortisone-like substances (Adrenal RindEnsteroide) or liquorice root are reinforced.

Dosage instructions, type and duration of the application:
How many of Legapas® tablets and how often should they be Legapas® Apply tablets?
The highest daily intake must not be more than 30 mg of hydroxyanthrate derivatives equivalent to 1 1/2 Film tablets Legapas® tablets.
Adults and children over 12 years occupy 1 to 11/2 film-coated tablets once a day or in the evening.
The personally correct dosage is the least needed to obtain a soft-shaped chair.
the Effect occurs after 8-12 hours.
Note:
Stimulating laxatives may not be accepted without a longer period of time (more than 1-2 weeks) without a medical advice.

Application error and overdose:
In the event of accidental or intended overdose, painful intestinal cramps and severe diarrhea may occur with the sequence of water and saline losses and possibly strong gastrointestinal complaints. For overdosed, please inform a doctor immediately. He will decide,
which countermeasures (eg supply of liquid and salts) if necessary, are required.

What do you need to consider if you have taken over by Legapas® tablets or forgot a dose?
Take the twice the amount next time, but follow the application as described in the dosing instructions.

Side effects:
Which side effects can be used in the application of Legapas® Tablets occur?
Very rare it can come to convulsive gastrointestinal complaints. In these cases, a reduction in the dose is required. In the course of treatment, a harmless red coloring of the urine can occur.
For long use or higher dosage (abuse) Can cause disturbances of the water and salt balance. Performing diarrhea can lead to potassium losses in particular. The potassium loss can lead to malfunction of heart function and muscle weakness, especially with simultaneous intake of
Heart glycosides (heart muscle strengthening medicines), diuretics (The urinary excretion increase drugs) and cortisone and cortisone-like substances (adrenal tongue steroids). For long-lasting use, it can lead to the excretion of protein and blood in the urine. Furthermore, a discoloration of the intestinal mucosa (Pseudomelanose coli) occurring, which usually returns after discontinuation of the preparation.
If you observe side effects that are not listed in this leaflet, please tell your doctor or pharmacist.

Note:
After the expiration of the expiry date indicated on the pushback and folding box, do not apply anymore.
Store over 25 ° C.

Date of the version: 21.02.2003
Source: Manufacturer information